Entrusted financial announcement
Release time:
2021-05-20
证券简称:尖峰集团 证券代码:600668 编号:临2020-030
浙江尖峰集团股份有限公司
委托理财公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
- 委托理财受托方:广发银行股份有限公司金华分行
- 委托理财金额:10,000万元人民币
- 委托理财产品名称:薪加薪16号XJXCKJ20516
- 委托理财投资类型:保本浮动收益型结构性存款
- 委托理财期限:2020年11月05日—2021年02月03日
- 履行的审议程序:2019年4月26日,公司召开的第十届董事会第10次会议审议通过了《关于授权公司董事长利用自有资金进行委托理财的议案》。授权公司董事长行使不超过人民币5亿元的委托理财的决策权,在该额度内资金可以滚动使用,但任一时点存续的委托理财余额合计不得超过5亿元,每笔委托理财的期限均不得超过12个月。详见本公司在2019年4月30日在上海证券交易所网站等披露的《关于授权公司董事长利用自有资金进行委托理财的公告》(临2019-012)。
一、本次委托理财概况
(一)委托理财目的
公司在不影响主营业务的正常开展、日常运营资金周转需要和资金安全的前提下,使用暂时闲置自有资金10,000万元购买广发银行股份有限公司金华分行发售的“薪加薪16号”XJXCKJ20516 W款人民币结构性存款产品。本产品为保本浮动收益型存款产品,安全性高、流动性好、风险性低。公司通过进行适度的低风险理财产品投资业务,有利于提高资金使用效率,且获得一定的理财收益。
(二)资金来源
本次委托理财的资金来源系公司自有资金。
(三)委托理财产品的基本情况
|
受托方 名称 |
产品 类型 |
产品 名称 |
金额 (万元) |
预计年化 收益率 |
预计收益金额 (万元) |
|
广发银行股份有限公司金华分行 |
银行结构性存款产品 |
薪加薪16号XJXCKJ20516 |
10,000 |
1.50%—3.10% |
36.99-76.44 |
|
产品 期限 |
收益 类型 |
结构化 安排 |
参考年化 收益率 |
预计收益 (万元) |
是否构成 关联交易 |
|
90天 |
保本浮动收益型 |
无 |
1.50%—3.10% |
36.99-76.44 |
否 |
(四)公司对委托理财相关风险的内部控制
1、委托理财情况由公司审计部门进行日常监督,定期对公司委托理财的进展情况、盈亏情况、风险控制情况和资金使用情况进行审计、核实。
2、公司进行委托理财,应当选择资信、财务状况良好、盈利能力强的合格专业理财机构作为受托方,并与受托方签订书面合同,明确委托理财的金额、期间、投资品种、双方的权利义务及法律责任等,必要时要求提供担保。公司董事会指派公司财务负责人跟踪委托理财的进展情况及投资安全状况。财务负责人发现公司委托理财出现异常情况时应当及时向董事会报告,以便董事会立即采取有效措施回收资金,避免或减少公司损失。
3、公司独立董事可以对委托理财情况进行检查。独立董事在公司内部审计核查的基础上,以董事会审计委员会核查为主,必要时由二名以上独立董事提议,有权聘任独立的外部审计机构进行委托理财的专项审计。独立董事应对提交董事会审议的委托理财事项发表独立意见。
4、公司监事会有权对公司委托理财情况进行定期或不定期的检查。如发现违规操作情况可提议召开董事会审议停止公司的相关投资活动。
5、公司委托理财具体执行人员及其他知情人员在相关信息公开披露前不得将公司投资情况透露给其他个人或组织,但法律、法规或规范性文件另有规定的除外。
6、凡违反相关法律法规、本制度及公司其他规定或由于工作不尽职,致使公司遭受损失或收益低于预期,将视具体情况,追究相关人员的责任。
本次公司购买广发银行发行的保本浮动收益型结构性存款,在前述董事会对董事长的授权范围内,该产品风险程度低,符合公司内部资金管理要求。
二、本次委托理财的具体情况
(一)委托理财合同主要条款
客户:浙江尖峰集团股份有限公司
银行:广发银行股份有限公司金华分行
|
产品名称 |
薪加薪16号XJXCKJ20516 |
|
产品代码 |
XJXCKJ20516 |
|
挂钩标的 |
交易日东京时间下午15:00点在彭博页面上“MID”标题下显示的美元兑日元汇率 |
|
产品期限 |
90天 |
|
产品类型 |
保本浮动收益型存款产品 |
|
本金保证 |
银行在本产品到期时保证存款本金 |
|
存款成立日 |
2020年11月05日 |
|
存款到期日 |
2021年02月03日 |
|
提前赎回、终止 |
本结构性存款产品到期日之前,投资者不具有主动申请该产品赎回的权利,即投资者无权单方面主动决定提前赎回本结构性存款产品。在投资者违约赎回的情况下,可能会损失部分本金及收益。 本结构性存款产品到期日之前,除遇法律法规、监管规定出现重大变更,要求本立品终止外,广发银行无权单方面主动决定提前终止本产品。 |
|
本金及收益支付 |
结构性存款到期日,广发银行向投资者归还结构性存款本金和应得的结构性存款收益,该结构性存款本金和结构性存款收益于到期日划转至投资者指定账户。 |
|
投资范围
|
本结构性存款本金部分纳入广发银行资金统一运作管理,投资者的结构性存款收益取决于美元兑日元在观察期内的表现。 |
|
结构性存款收益说明 |
期初价格:期初价格定义为结构性存款启动日当天的定盘价格,本结构性存款计划即为2020年11月05日的定盘价格。 如果在该日挂钩标的发生干扰市场事件或市场特殊事件,则按照对干扰市场事件或市场特殊事件的处理来确定该挂钩标的的期初价格。 期末价格:期末价格定义为结构性存款结算日当天的定盘价格,本结构性存款计划即为2021年02月01日的定盘价格。 如果在该日挂钩标的发生干扰市场事件或市场特殊事件,则按照对干扰市场事件或市场特殊事件的处理来确定该挂钩标的的期末价格。 观察区间上限:期初价格+4.90 观察区间下限:期初价格-4.90 观察期:从结构性存款启动日(含)的东京时间下午15:00起直至结构性存款结算日(含)的东京时间下午15:00止的全部交易日。 有效天数:在观察期的所有交易日中,标的每日收盘价处于观察区间上限和观察区间下限之间(含界限)的天数。 收益率(年化):1.5%+1.60%*有效天数/交易日天数 结构性存款收益率的确定: 结构性存款收益率根据以下公式来确定: 产品观察期间(即起息日至结算日期间投资标的的交易日,含结算日),美元兑日元汇率处于观察区间上限和观察区间下限之间(含界限)的天数为有效天数,收益计算方法为: 1.5%+1.60%*有效天数/交易日天数。 |
|
预期收益计算方法 |
投资者获得的结构性存款收益=结构性存款本金×到期年化收益率×实际结构性存款天数÷365,精确到小数点后2位。
|
(二)委托理财的资金投向
本次公司委托理财的资金投向为广发银行结构性存款产品。
(三)风险控制分析
公司本次使用自有资金购买广发银行金华分行发售的保本浮动收益型结构性存款,在公司第十届董事会第10次会议授权董事长决策范围之内。公司财务部建立台账负责对短期理财产品进行管理,建立健全会计账目,做好资金使用的财务核算工作。公司在本次交易后将履行信息披露义务,并实时跟踪进展情况及时披露。
广发银行结构性存款属于保本浮动收益型产品,广发银行股份有限公司金华分行承诺保障结构性存款本金,因此该产品风险程度较低,符合公司《委托理财管理制度》的要求。
三、委托理财受托方的情况
(一)受托方的基本情况
|
名称 |
成立时间 |
法定代表人 |
注册 资本 (万元) |
主营业务 |
主要股东及实际控制人 |
是否为本次交易专设 |
|
广发银行股份有限公司 |
1988-07-08 |
尹兆君 |
1968719.6272 |
吸收公众存款;发放短期、中期和长期贷款;办理国内外结算;办理票据承兑与贴现;发行金融债券;代理发行、代理兑付、承销政府债券;买卖政府债券、金融债券等有价证券;从事同业拆借;提供信用证服务及担保;从事银行卡业务;代理收付款项及代理保险业务;提供保管箱服务;外汇存、贷款;外汇汇款;外币兑换;国际结算;结汇、售汇;同业外汇拆借;外汇票据的承兑和贴现;外汇借款;外汇担保;买卖和代理买卖股票以外的外币有价证券;发行和代理发行股票以外的外币有价证券;自营和代客外汇买卖;代理国外信用卡的发行及付款业务;离岸金融业务;资信调查、咨询、见证业务;经中国银监会等批准的其他业务。(依法须经批准的项目,经相关部门批准后方可开展经营活动) |
中国人寿保险(集团)公司 |
否 |
(二)受托方最近一年主要财务指标
截至2019年12月31日,广发银行股份有限公司总资产26,327.98亿元,归属于股东的净资产2,095.64亿元;2019年营业收入763.12亿元,归属于股东的净利润125.81亿元。
(三)广发银行股份有限公司与本公司之间在产权、业务、资产、债权债务、人员等方面均不存在关联关系。
四、对公司的影响
(一)本公司最近一年又一期主要财务指标
单位:万元
|
项目 |
2019年12月31日 |
2020年9月30日 |
|
总资产 |
547,517.79 |
610,942.80 |
|
总负债 |
139,487.88 |
157,117.13 |
|
归属于公司股东的净资产 |
378,910.99 |
426,929.92 |
|
|
2019年度 |
2020年1-9月 |
|
经营性现金流量净额 |
51,998.13 |
24,611.67 |
|
营业收入 |
354,753.76 |
224,065.44 |
|
归属于公司股东的净利润 |
72,468.81 |
51,623.07 |
公司本次购买广发银行结构性存款理财产品是在不影响主营业务的正常开展、日常运营资金周转需要和资金安全的前提下,使用短期闲置自有资金进行委托理财业务,有利于提高公司资金使用效率。
(二)截止2020年9月30日,公司货币资金为26,471.11万元,本次购买广发银行结构性存款支付的金额占最近一期期末货币资金的37.78%,对本公司未来主营业务、财务状况、经营成果和现金流量等不会造成重大的影响。
(三)根据企业会计准则第22号—《金融工具确认和计量》规定,该结构性银行存款符合以摊余成本计量的金融资产,列示于资产负债表—其他流动资产,利息收益计入利润表—投资收益。
五、风险提示
尽管本公司购买的结构性存款属于短期保本浮动收益型的低风险理财产品,但金融市场受宏观经济影响较大,不排除该项投资受到市场风险、信用风险、政策风险、流动性风险、不可抗力风险等风险从而影响收益。
六、独立董事意见
公司召开的第十届董事会第10次会议审议通过了《关于授权公司董事长决定委托理财的议案》,独立董事发表了独立意见,认为:该决议的形成符合《公司法》、公司《章程》等有关规定,没有损害中小股东的利益。
七、截至本公告日,公司最近十二个月使用自有资金或募集资金委托理财的情况 单位:万元
|
序号 |
理财产品类型 |
实际投入 金额 |
实际收回 本金 |
实际收益 |
尚未收回 本金金额 |
|
1 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
10,000.00 |
33.75 |
/ |
|
2 |
渤海银行S191620号结构性存款理财产品 |
5,000.00 |
5,000.00 |
50.49 |
/ |
|
3 |
渤海银行S192012号结构性存款理财产品 |
3,000.00 |
3,000.00 |
29.92 |
/ |
|
4 |
慧盈人民币单位结构性存款产品 |
3,000.00 |
3,000.00 |
29.96 |
/ |
|
5 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
5,000.00 |
50.55 |
/ |
|
6 |
结构性存款 |
5,000.00 |
5,000.00 |
18.74 |
/ |
|
7 |
慧盈人民币单位结构性存款产品 |
5,000.00 |
5,000.00 |
49.91 |
/ |
|
8 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
10,000.00 |
100.97 |
/ |
|
9 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
100.82 |
/ |
|
10 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
92.66 |
/ |
|
11 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
5,000.00 |
42.67 |
/ |
|
12 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
79.59 |
/ |
|
13 |
薪加薪16号人民币结构性存款产品 |
15,000.00 |
/ |
/ |
15,000.00 |
|
14 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
10,000.00 |
39.07 |
/ |
|
15 |
汇利丰2020年6156期对公定制人民币结构性存款产品 |
7,000.00 |
/ |
/ |
7,000.00 |
|
16 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
/ |
/ |
5,000.00 |
|
17 |
招商银行结构性存款NHZ00043 |
5,000.00 |
/ |
/ |
5,000.00 |
|
18 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
/ |
/ |
10,000.00 |
|
合计 |
133,000.00 |
91,000.00 |
719.10 |
42,000.00 |
|
|
最近12个月内单日最高投入金额 |
50,000.00 |
||||
|
最近12个月内单日最高投入金额/最近一年净资产(%) |
13.20 |
||||
|
最近12个月委托理财累计收益/最近一年净利润(%) |
0.99 |
||||
|
目前已使用的理财额度 |
42,000.00 |
||||
|
尚未使用的理财额度 |
8,000.00 |
||||
|
总理财额度 |
50,000.00 |
||||
特此公告
浙江尖峰集团股份有限公司
董事会
二〇二〇年十一月六日
More information
The company's "three" cultivation through the stage of acceptance
Since November 2015 was included in the second batch of "three" cultivation pilot enterprises in Zhejiang Province, the company has carried out a series of related work in depth. On October 19, the implementation of the company's "three" cultivation project from January 2016 to September 2017 passed the phased acceptance organized by Jinhua Economic and Information Commission and Jinhua Finance Bureau. According to the requirements of the "three" cultivation pilot enterprise responsibility letter signed with Zhejiang Province, Jinhua City and Wucheng District, as of the end of September 2017, the company has invested 16.0772 million yuan in related projects, and has achieved remarkable results in improving management, improving automation and informatization level. For example, after the digital system of quality and cost control in the plant extraction workshop of Jianfeng Health Technology Company is put into use, the whole production process can be controlled and traceable, the product quality is more stable, the production safety is effectively guaranteed, the "three wastes" emission is greatly reduced, and the product cost is reduced by 20%. The electronic label system of the pharmaceutical company automatically addresses and accurately locates the drugs in and out of the warehouse, which reduces the error rate of the out and into the warehouse, and the location management can automatically display the information such as the location and quantity of the drugs, which improves the work efficiency of the warehouse logistics and effectively reduces the management cost. The pharmaceutical company's sales management information system integrates sales management, warehouse management, customer management, statistical analysis and other modules, realizes drug sales management and control functions according to the requirements of GMP and GSP specifications, and analyzes drug regions and sales volume through big data, which will judge drug consumption trends faster and more accurately and improve the accuracy of the company's drug sales decisions. Health
2020
07-31
The company's "three" cultivation through the stage of acceptance
Since November 2015 was included in the second batch of "three" cultivation pilot enterprises in Zhejiang Province, the company has carried out a series of related work in depth. On October 19, the implementation of the company's "three" cultivation project from January 2016 to September 2017 passed the phased acceptance organized by Jinhua Economic and Information Commission and Jinhua Finance Bureau. According to the requirements of the "three" cultivation pilot enterprise responsibility letter signed with Zhejiang Province, Jinhua City and Wucheng District, as of the end of September 2017, the company has invested 16.0772 million yuan in related projects, and has achieved remarkable results in improving management, improving automation and informatization level. For example, after the digital system of quality and cost control in the plant extraction workshop of Jianfeng Health Technology Company is put into use, the whole production process can be controlled and traceable, the product quality is more stable, the production safety is effectively guaranteed, the "three wastes" emission is greatly reduced, and the product cost is reduced by 20%. The electronic label system of the pharmaceutical company automatically addresses and accurately locates the drugs in and out of the warehouse, which reduces the error rate of the out and into the warehouse, and the location management can automatically display the information such as the location and quantity of the drugs, which improves the work efficiency of the warehouse logistics and effectively reduces the management cost. The pharmaceutical company's sales management information system integrates sales management, warehouse management, customer management, statistical analysis and other modules, realizes drug sales management and control functions according to the requirements of GMP and GSP specifications, and analyzes drug regions and sales volume through big data, which will judge drug consumption trends faster and more accurately and improve the accuracy of the company's drug sales decisions. Health
2020
07-30
Yunnan Jianfeng supplies cement directly to Wa State of Myanmar
Yunnan Jianfeng Cement Company not only consolidates the original domestic market, but also gives full play to the location advantages of the three counties (Lancang, Menglian and Ximeng) close to the border to continuously expand the foreign market. Recently, the marketing department took the initiative to step out of the country from the Mangxin port in Menglian County and successfully sold "Jianfeng" brand cement to the newly planned Jinhua Xiaozunhe Island Development Zone in the Wa State of Myanmar. With the rapid development of China's economy in recent years, Myanmar has also increased the development of the China-Myanmar border area year by year. In order to attract more Chinese tourists to spend in transit, the Wa State Government of Myanmar has planned the Jinhua Xiaozunhe Island Development Zone near China's Menglian Mangxin Port. After the development zone is completed, it will mainly focus on gambling, business hotels, and border trade. There is an estimated demand for about 80000 tons of cement. When Yunnan Jianfeng marketing personnel learned of the news, they went deep into the development zone many times to understand the situation and had extensive contact with customers. With the good reputation of Jianfeng Cement in southwest Yunnan in recent years, they successfully signed a supply contract with a commercial mixing station in the development zone. At present, Yunnan Jianfeng has directly supplied 1200 tons of cement through Mangxin Port, and is expected to win 80% of the cement supply business of the development project. The initiative of "Belt and Road Initiative" to open up the international channels of South Asia and Southeast Asia has brought new development opportunities to many enterprises. This time, Yunnan Jianfeng Marketing Department went abroad to seize the opportunity, breaking the previous practice that the company mainly relied on agents for cement export, and achieved a new breakthrough in directly connecting users, which not only increased revenue, but also further expanded the radiation scope of its own marketing network, so as to further expand the scope of going abroad in the future.
2020
07-31
The company's "three" cultivation through the stage of acceptance
Since November 2015 was included in the second batch of "three" cultivation pilot enterprises in Zhejiang Province, the company has carried out a series of related work in depth. On October 19, the implementation of the company's "three" cultivation project from January 2016 to September 2017 passed the phased acceptance organized by Jinhua Economic and Information Commission and Jinhua Finance Bureau. According to the requirements of the "three" cultivation pilot enterprise responsibility letter signed with Zhejiang Province, Jinhua City and Wucheng District, as of the end of September 2017, the company has invested 16.0772 million yuan in related projects, and has achieved remarkable results in improving management, improving automation and informatization level. For example, after the digital system of quality and cost control in the plant extraction workshop of Jianfeng Health Technology Company is put into use, the whole production process can be controlled and traceable, the product quality is more stable, the production safety is effectively guaranteed, the "three wastes" emission is greatly reduced, and the product cost is reduced by 20%. The electronic label system of the pharmaceutical company automatically addresses and accurately locates the drugs in and out of the warehouse, which reduces the error rate of the out and into the warehouse, and the location management can automatically display the information such as the location and quantity of the drugs, which improves the work efficiency of the warehouse logistics and effectively reduces the management cost. The pharmaceutical company's sales management information system integrates sales management, warehouse management, customer management, statistical analysis and other modules, realizes drug sales management and control functions according to the requirements of GMP and GSP specifications, and analyzes drug regions and sales volume through big data, which will judge drug consumption trends faster and more accurately and improve the accuracy of the company's drug sales decisions. Health
2020
07-31
"We were also praised by the traffic police." On September 26, when talking about the civilized travel volunteer activities a few days ago, Li Xuegen of the big pharmacy smiled and was very happy that his work was recognized. Starting from May this year, during the rush hour on the 5th and 20th of each month (weekends and holidays are postponed), there will be a group of volunteers wearing red vests and hats, holding signs with the words "courtesy of zebra crossing, civilized crossing of the road" to divert traffic at many intersections in the city. This is a civilized travel volunteer service activity carried out by Jinhua City to further promote civilized travel and persuade uncivilized behavior. As a civilized unit at the municipal level in Jinhua, Jianfeng Group's duty junction is at the intersection of Bayi North Street and Zhongshan West Road. Before the activity was carried out, as the organizer of the group company, the group office had deep concerns. The activity took a long time and required a lot of manpower. As an enterprise, under the condition of ensuring normal production, it was completed by employees in their spare time. Can it be continued? To this end, Xiang Chongping, the leader in charge of the group company, specially organized a meeting of the directors of the subordinate enterprise offices to mobilize and deploy the matter. The group office also specially established the QQ group of "Peak Civilized Travel Volunteer Service" to release the contents and arrangements of the activities, update the duty situation, and praise the small partners on duty. At the beginning of the activity, colleagues in the headquarters building took the lead in taking up their posts. The first class was Li Hong, Li Xia, Yang Liu and Lei Yuan of the finance department of the group company. Employees of the group office, the peak health experience hall, Qiubin Factory and the international trading company also took up their posts one after another. Other enterprises also took part in an orderly manner according to the duty schedule.
2020
07-31
Daye peak again won the national inspection big contrast "all-excellent award"
A few days ago, daye peak cement co., ltd won the "all-excellent award" in the 16th national cement quality index inspection comparison of "hongchao science and technology cup" organized by the national cement quality supervision and inspection center in 2017 ". The national cement quality index inspection is held every two years. It is the highest level competition in the cement industry. It aims to understand the current quality inspection level of China's cement industry through large-scale comparison, promote various cement inspection departments to improve the inspection quality, and provide accurate data for cement production and use. The results truly reflect the overall inspection level of national cement production enterprises and provincial building materials (cement) inspection stations, it represents the highest level of inspection technology in the cement industry. Over the years, Daye Peak has firmly established the concept of "quality is the life of an enterprise", always puts product quality control in the first place, and conducts daily inspections in strict accordance with the testing items and frequency specified by national standards. actively carry out inspection comparison with provincial and municipal cement quality inspection centers, improve the professional level of inspectors through skill training, and spot check the internal passwords of inspectors every month to strictly ensure the accuracy and reliability of data, to ensure that the quality of the factory cement to meet the market and customer demand, and further enhance the core competitiveness of enterprises. Since it was officially put into production in 2008, Daye Peak has participated in the national cement quality index inspection five times, and has achieved good results. Among them, it won the "All-Excellent Award" in 2009 and the "All-Qualified" in 2011, 2013 and 2015. Unit Award ". (Yang Huiping)
2020
07-31